Makoto Ota
Founder bij WELBE, INC.
Vermogen: 39 M $ op 31-03-2024
Actieve functies van Makoto Ota
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| WELBE, INC. | Director/Board Member | 01-12-2011 | - |
| Founder | 01-12-2011 | - | |
| President | 01-12-2011 | - | |
| Welbe Healthcare, Inc. | Director/Board Member | 01-06-2021 | - |
Loopbaan van Makoto Ota
Eerdere bekende functies van Makoto Ota
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELLA, INC. | Director/Board Member | 01-11-2004 | - |
Statistieken
Internationaal
| Japan | 3 |
| 2 |
Operationeel
| Director/Board Member | 3 |
| Founder | 1 |
| President | 1 |
Sectoraal
| Health Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Welbe, Inc. | |
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Beurs
- Insiders
- Makoto Ota
- Ervaring
